November 2, 2020
Christie recently introduced its CounterAct line of UV disinfection fixtures that provides Care222 far-UVC light technology for disinfecting. Developed by Christie's parent company Ushio Inc., these solutions include a short pass filter to prevent longer wavelengths of UV light from entering human skin or eyes, according to a press release.
Users can install CounterAct fixtures on a ceiling the same way as a traditional light fixture. It can get rid of more than 99.7% of surface contamination of the virus that causes COVID-19: Severe Acute Respiratory Syndrome Coronavirus 2.
"People are essential to the entertainment industry, and their level of comfort in public venues is paramount to the industry's success. We are very proud to be able to offer this product with Ushio's Care222 technology to our partners, and we are excited about the possibilities the technology will have in bringing customers back to the places they love, such as movie theaters and theme parks," Zoran Veselic, president and COO, Christie, said in the release. "The fact that far-UVC light – specifically, our new Christie CounterAct far-UVC fixture – can be used in the presence of people is a real differentiating factor. By harnessing these benefits as part of a user-friendly product that can be quickly deployed, we hope to provide a much-needed boost to our partners across the entertainment industry who are currently struggling to attract wary customers."